This webinar will be held on Tuesday, August 18th, at 5PM Pacific Tome, and will be led by Atul Dandekar.
Speaker: Atul Dandekar, Chief Strategy & Business Officer of Maze Therapeutics, will share the business perspective of building a biotech company
Atul leads strategy, partnering, corporate development, and portfolio management. Atul brings more than 20 years of experience in strategy, clinical development and commercialization. Most recently, he was vice president, global franchise head for ophthalmology at Genentech and Roche, where he was responsible for leading the global ophthalmology business. He led the development of the global Roche ophthalmology strategy and led the ophthalmology cross-Roche Team that helped develop faricimab, PDS with ranibizumab and an industry leading retina pipeline.
Prior to this role, he led the Phase 3 development programs for faricimab and lampalizumab. Before joining Genentech in 2014, Atul was the senior global program head in neuroscience at Novartis. During his 16-year tenure at Novartis, Atul held roles of increasing responsibility in diverse areas of clinical development, disease area strategy and marketing in India, Australia and Switzerland.
He is the co-founder of Ollin Biosciences, a clinical stage ophthalmology company.
Atul holds degrees in medicine and management from Mumbai University and a Master’s in marketing management from Monash University.
A new international research project, CILIOTACTIC, was launched in early September. Thanks to funding from the prestigious Horizon Europe Marie Skłodowska-Curie Postdoctoral Fellowships program, Annette Jacobsen, an early-career researcher specialising in primary cilia, has joined Lukáš Čajánek’s research group at the Institute of Histology and Embryology.
This series of lectures, intended for the general public, builds on the legacy of Gregor Johann Mendel and offers a unique opportunity to learn about the latest discoveries in the beautiful setting of the Mendel Refectory, discuss current social and scientific challenges, and meet leading experts from the international academic community. Začínáme již 15. října.
